書誌事項
- タイトル別名
-
- Investigation of Clinical Outcome and Prognosis of 2nd TUR-Bt for T1 High Grade Bladder Cancer
- T1 high grade ノ ボウコウ ガン ニ タイスル 2nd TUR-Bt ノ リンショウ セイセキ オヨビ ヨゴ ノ ケントウ
この論文をさがす
説明
Second transurethral resection of bladder tumor (TUR-Bt) is a standard treatment for high grade T1 initial, non-muscle invasive bladder cancer. In our hospital from October 2008 to April 2017, 2nd TUR-Bt was performed in 51 cases of initial T1 bladder cancer. The risk factors of residual tumors on 2nd TUR-Bt and the clinical outcome were examined retrospectively. Twenty two of the 51 cases (43.1%) had residual tumors on 2nd TUR-Bt, and upstaging was not admitted. To determine the risk factor for residual tumors in 2nd TUR-Bt, we examined gender, tumor morphology (papillary/non-papillary, pedunculated/ nonpedunculated), number of tumors (single/frequent), and tumor size (≧20 mm/<20 mm), but none of these were significant risk factors for tumor residue. The recurrence free survival (RFS) of the 51 cases was 86.0% after 1 year, and 77.0% after 3 years. There tended to be a higher RFS in the pedunculated tumor group, pT0 group on 2nd TUR-Bt, intravesical BCG therapy group, but no statistically significant difference was observed. The progression free survival (PFS) was 90.6% after 3 years, and 87.3% after 5 years. These values were similar to those reported previously.
収録刊行物
-
- 泌尿器科紀要
-
泌尿器科紀要 65 (4), 105-109, 2019-04-30
泌尿器科紀要刊行会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390853649777435648
-
- NII論文ID
- 120006647315
-
- NII書誌ID
- AN00208315
-
- HANDLE
- 2433/242255
-
- NDL書誌ID
- 029642009
-
- ISSN
- 00181994
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- IRDB
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用可